Progress in primary immunodeficiency
- 作者Shuzo Matsumoto; Yukio Sakiyama; Tadashi Ariga; Richard Gallagher; Yuichi Taguchi
- 卷第13卷
- 期第1期
- 印刷ISSN0167-5699
- 文件大小217.91KB
- 发表时间1992
- DOI10.1016/0167-5699(92)90195-d
- 页码4-5
T cell targeted immunotherapy for autoimmune diseaseLee, Erica; Sinha, Animesh A. · Autoimmunity · 2005
Cytokine-Functionalized Synthetic Dendritic Cells for T Cell Targeted ImmunotherapiesEggermont, Loek J.; Hammink, Roel; Blank, Kerstin G.; Rowan, Alan E.; Tel, Jurjen; Figdor, Carl G. · Advanced Therapeutics · 2018
T cell-based targeted immunotherapies for patients with multiple myelomaWang, Lei; Jin, Nan; Schmitt, Anita; Greiner, Jochen; Malcherek, Georg; Hundemer, Michael; Mani, Jiju; Hose, Dirk; Raab, Marc S; Ho, Anthony D.; Chen, Bao-an; Goldschmidt, Hartmut; Schmitt, Michael · International Journal of Cancer · 2015
Oral histone deacetylase inhibitor synergises with T cell targeted immunotherapy to preserve beta cell metabolic function and induce stable remission of new-onset autoimmune diabetes in NOD miceBesançon, Alix; Goncalves, Tania; Valette, Fabrice; Dahllöf, Mattias S.; Mandrup-Poulsen, Thomas; Chatenoud, Lucienne; You, Sylvaine · Diabetologia · 2017